ReP USP - Resultado da busca

Artigo de periodico
Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia (2020)
Oliveira, Milena Locci de ; Rocha, Adriana; Nardotto, Glauco Henrique Balthazar ; Pippa, Leandro Francisco ; Simões, Belinda Pinto ; Lanchote, Vera Lucia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FCFRP, FMRP
Subjects: LEUCEMIA MIELOIDE AGUDA, ANTINEOPLÁSICOS, METABÓLITOS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Milena Locci de et al. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia. Journal of Pharmaceutical and Biomedical Analysis, v. 191, p. 1-8, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2020.113576. Acesso em: 04 jul. 2024.
APA
Oliveira, M. L. de, Rocha, A., Nardotto, G. H. B., Pippa, L. F., Simões, B. P., & Lanchote, V. L. (2020). Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia. Journal of Pharmaceutical and Biomedical Analysis, 191, 1-8. doi:10.1016/j.jpba.2020.113576
NLM
Oliveira ML de, Rocha A, Nardotto GHB, Pippa LF, Simões BP, Lanchote VL. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 191 1-8.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1016/j.jpba.2020.113576
Vancouver
Oliveira ML de, Rocha A, Nardotto GHB, Pippa LF, Simões BP, Lanchote VL. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 191 1-8.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1016/j.jpba.2020.113576
Artigo de periodico
Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: application in a clinical pharmacokinetic study of single oral dose (2019)
Cestari, Roberta Natália; Rocha, Adriana; Marques, Maria Paula ; Oliveira, Renê Donizeti Ribeiro de; Lanchote, Vera Lucia
Source: Journal of Chromatography B. Unidades: FCFRP, FMRP
Subjects: ESTATINAS, METABÓLITOS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CESTARI, Roberta Natália et al. Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: application in a clinical pharmacokinetic study of single oral dose. Journal of Chromatography B, v. 1126-1127, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jchromb.2019.121766. Acesso em: 04 jul. 2024.
APA
Cestari, R. N., Rocha, A., Marques, M. P., Oliveira, R. D. R. de, & Lanchote, V. L. (2019). Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: application in a clinical pharmacokinetic study of single oral dose. Journal of Chromatography B, 1126-1127. doi:10.1016/j.jchromb.2019.121766
NLM
Cestari RN, Rocha A, Marques MP, Oliveira RDR de, Lanchote VL. Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: application in a clinical pharmacokinetic study of single oral dose [Internet]. Journal of Chromatography B. 2019 ; 1126-1127[citado 2024 jul. 04 ] Available from: https://doi.org/10.1016/j.jchromb.2019.121766
Vancouver
Cestari RN, Rocha A, Marques MP, Oliveira RDR de, Lanchote VL. Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: application in a clinical pharmacokinetic study of single oral dose [Internet]. Journal of Chromatography B. 2019 ; 1126-1127[citado 2024 jul. 04 ] Available from: https://doi.org/10.1016/j.jchromb.2019.121766
Artigo de periodico
Influence of quinidine, cimetidine, and ketoconazole on the enantioselective pharmacokinetics and metabolism of metoprolol in rats (2009)
Boralli, Vanessa Bergamin; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia
Source: Chirality. Unidades: FMRP, FCFRP
Subjects: METABÓLITOS, FARMACOCINÉTICA, HIPERTENSÃO (TRATAMENTO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORALLI, Vanessa Bergamin e COELHO, Eduardo Barbosa e LANCHOTE, Vera Lúcia. Influence of quinidine, cimetidine, and ketoconazole on the enantioselective pharmacokinetics and metabolism of metoprolol in rats. Chirality, v. 21, n. 10, p. 886-893, 2009Tradução . . Disponível em: https://doi.org/10.1002/chir.20682. Acesso em: 04 jul. 2024.
APA
Boralli, V. B., Coelho, E. B., & Lanchote, V. L. (2009). Influence of quinidine, cimetidine, and ketoconazole on the enantioselective pharmacokinetics and metabolism of metoprolol in rats. Chirality, 21( 10), 886-893. doi:10.1002/chir.20682
NLM
Boralli VB, Coelho EB, Lanchote VL. Influence of quinidine, cimetidine, and ketoconazole on the enantioselective pharmacokinetics and metabolism of metoprolol in rats [Internet]. Chirality. 2009 ; 21( 10): 886-893.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1002/chir.20682
Vancouver
Boralli VB, Coelho EB, Lanchote VL. Influence of quinidine, cimetidine, and ketoconazole on the enantioselective pharmacokinetics and metabolism of metoprolol in rats [Internet]. Chirality. 2009 ; 21( 10): 886-893.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1002/chir.20682
Artigo de periodico
Capillary electrophoretic chiral determination of mirtazapine and its main metabolites in human urine after enzymatic hydrolysis (2008)
Santana, Fernando José Malageño de; Lanchote, Vera Lúcia; Bonato, Pierina Sueli
Source: Electrophoresis. Unidade: FCFRP
Subjects: ENZIMAS HIDROLÍTICAS, METABÓLITOS, URINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTANA, Fernando José Malageño de e LANCHOTE, Vera Lúcia e BONATO, Pierina Sueli. Capillary electrophoretic chiral determination of mirtazapine and its main metabolites in human urine after enzymatic hydrolysis. Electrophoresis, v. 29, n. 18, p. 3924-3932, 2008Tradução . . Disponível em: https://doi.org/10.1002/elps.200800053. Acesso em: 04 jul. 2024.
APA
Santana, F. J. M. de, Lanchote, V. L., & Bonato, P. S. (2008). Capillary electrophoretic chiral determination of mirtazapine and its main metabolites in human urine after enzymatic hydrolysis. Electrophoresis, 29( 18), 3924-3932. doi:10.1002/elps.200800053
NLM
Santana FJM de, Lanchote VL, Bonato PS. Capillary electrophoretic chiral determination of mirtazapine and its main metabolites in human urine after enzymatic hydrolysis [Internet]. Electrophoresis. 2008 ; 29( 18): 3924-3932.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1002/elps.200800053
Vancouver
Santana FJM de, Lanchote VL, Bonato PS. Capillary electrophoretic chiral determination of mirtazapine and its main metabolites in human urine after enzymatic hydrolysis [Internet]. Electrophoresis. 2008 ; 29( 18): 3924-3932.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1002/elps.200800053

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Funding Agencies

Indexado em